SCHEMBL3954129

SCHEMBL3954129

COc1cc2ncnc(Nc3nc4ccc(NC(=O)c5ccccc5OC)cc4s3)c2cc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.72
AURKA O14965 2/20 0.57
AURKB Q96GD4 2/20 0.57
EGFR P00533 4/20 0.55
MAPK14 Q16539 3/20 0.55
RAB9A P51151 2/20 0.53
NPC1 O15118 1/20 0.53
PKM P14618 1/20 0.53
PAX8 Q06710 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MEN1 O00255 2/20 0.53
ALDH1A1 P00352 2/20 0.53
HPGD P15428 2/20 0.53
KMT2A Q03164 2/20 0.53
LMNA P02545 1/20 0.53
POLB P06746 1/20 0.53
MAPT P10636 1/20 0.53
BLM P54132 1/20 0.53
MCL1 Q07820 1/20 0.53
KDM4E B2RXH2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3947988 0.90 AURKB (0.71) KDRAURKAAURKBEGFRMAPK14
SCHEMBL3947519 0.88 EGFR (0.69) KDRAURKAAURKBEGFR
SCHEMBL3949732 0.88 KDR (0.72) KDRAURKAAURKBEGFRMAPK14
SCHEMBL3947263 0.88 KDR (0.72) KDRAURKAAURKBEGFRMAPK14
SCHEMBL3949246 0.87 KDR (0.60) KDRAURKAAURKBEGFRMAPK14
SCHEMBL3949424 0.86 KDR (0.61) KDRAURKAAURKBEGFRMAPK14
SCHEMBL3945122 0.85 KDR (0.60) KDRAURKAAURKBEGFRMAPK14
SCHEMBL3946532 0.85 KDR (0.74) KDREGFRRAB9ANPC1MEN1
SCHEMBL3949215 0.85 KDR (0.60) KDRAURKAAURKBEGFRMAPK14
SCHEMBL3947622 0.85 KDR (0.73) KDRAURKAAURKBEGFRMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514460-B2 Benzazole analogues and uses thereof 4SC AG (DE) 2009-04-07 US disclosed
US-7514460-B2 Benzazole analogues and uses thereof 4SC AG (DE) 2009-04-07 US disclosed
US-7514460-B2 Benzazole analogues and uses thereof 4SC AG (DE) 2009-04-07 US disclosed
EP-1674467-A1 2,5- and 2,6-disubstituted benzazole derivatives useful as protein kinase inhibitors 4SC AG (DE) 2006-06-28 EP disclosed
US-20060135782-A1 Benzazole analogues and uses thereof 4SC AG (DE) 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135782-A1 Benzazole analogues and uses thereof DCK, SBK3, DAPK3 KDR 1657/4885AURKA 139/4885AURKB 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.